Vaccine stocks fall after key FDA official resigns in protest of RFK Jr.
1. FDA's Peter Marks resigned, raising concerns in biotech and vaccine sectors. 2. Shares of major vaccine makers, including BNTX, may face pressure. 3. Analysts express fear over the FDA's independence impacting drug approvals. 4. New FDA leadership could influence biotech stocks' performance moving forward. 5. Marks' resignation reflects wider issues in public confidence about vaccines.